Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
V Spustova
Observed name:
V Spustová
OpenAlex ID:
A5113769991
Participation of P-dependent and P-independent glutaminases in rat kidney ammoniagenesis and their modulation by metabolic acidosis, hippurate and insulin.
1998
·
Z Krivosíková
, V Spustová
, et al.
·
PubMed
·
33
Hippurate participation in the inhibition of glucose utilization in renal failure.
1987
·
V Spustová
, R Dzúrik
, et al.
·
PubMed
·
20
Plasma tryptophan level in chronic renal failure.
1980
·
P Cernácek
, H Becvárová
, et al.
·
PubMed
·
11
Serum hippurate and its excretion in conservatively treated and dialysed patients with chronic renal failure.
1991
·
V Spustová
, M Gajdos
, et al.
·
PubMed
·
10
Antitumor effect of hippurate. An experimental study using various mouse tumor strains.
1989
·
V Spustová
, C Oravec
·
PubMed
·
7
Enalapril in subantihypertensive dosage attenuates kidney proliferation and functional recovery in normotensive ablation nephropathy of the rat.
1999
·
Z Krivosíková
, K Sebeková
, et al.
·
PubMed
·
6
Relation between middle molecules and parathyroid hormone in patients with chronic renal failure.
1982
·
P T Fröhling
, F Kokot
, et al.
·
PubMed
·
5
[Nitric oxide and the kidneys].
2001
·
R Dzúrik
, V Spustová
·
PubMed
·
4
31P NMR investigation of free intracellular magnesium, pH and energy balance in striated muscle of patients with kidney disease: relation to insulin resistance.
1999
·
K Sebekova
, K Stefikova
, et al.
·
PubMed
·
3
A procedure for the isolation of an inhibitor of sodium transport from the urine of uraemic patients.
1982
·
R Dzúrik
, B Lichardus
, et al.
·
PubMed
·
3
[Celiprolol improves glucose metabolism in essential hypertension].
1998
·
A Oksa
, V Fedelesová
, et al.
·
PubMed
·
2
Erythrocyte transport of middle molecular substances.
1981
·
M Gajdos
, V Spustová
, et al.
·
PubMed
·
2
Concentration of plasma middle molecular weight substances and clinical condition of patients undergoing short-time regular dialysis treatment.
1981
·
A Válek
, R Dzúrik
, et al.
·
PubMed
·
2
Metabolic actions of middle molecules.
1981
·
R Dzúrik
, V Spustová
·
PubMed
·
2
Modulators and mediators of kidney disease progression: new targets of prevention and treatment.
1997
·
R Dzúrik
, P Pontuch
, et al.
·
PubMed
·
1
[Insulin resistance in kidney diseases].
1995
·
V Spustová
, K Stefíková
, et al.
·
PubMed
·
1
Metabolic effects of enalapril in the treatment of essential hypertension.
1992
·
A Oksa
, K Stefíková
, et al.
·
PubMed
·
1
Essential hypertension and insulin resistance.
1991
·
R Dzúrik
, J Málková
, et al.
·
PubMed
·
1
P-aminohippurate accumulation in kidney cortex slices: stimulation by dicarboxylates, amino acids and their oxoanalogues.
1991
·
R Dzúrik
, M Geryková
, et al.
·
PubMed
·
1
Effect of hippurate on tissue fatty acid metabolism.
1990
·
V Chorváthová
, R Ondreicka
, et al.
·
PubMed
·
1
[Nephrologic manifestations of mitochondrial diseases].
2000
·
R Dzúrik
, K Gazdíková
, et al.
·
PubMed
[The role of platelet-derived growth factor in progression of nephropathy].
1996
·
V Spustová
, A Oksa
, et al.
·
PubMed
[The role of thromboxane in the pathogenesis of nephropathies].
1996
·
R Dzúrik
, Z Krivosíková
, et al.
·
PubMed
[Prevention and therapy of atherosclerosis].
1996
·
M Gajdos
, S Cagán
, et al.
·
PubMed
[A protein-restricted diet combined with ACE inhibitors does not improve insulin sensitivity in renal hypertension].
1996
·
V Spustová
, K Stefiková
, et al.
·
PubMed
Show more works
View as search
Works count:
51
Citation count:
116
H-index:
6
I10-index:
4
Year
Topic
Type
